SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending following news of its progress supporting NVIDIA's next-generation AI factory computing platforms, specifically focused on 800V power architecture. The community is discussing the potential for a short squeeze and the company's role in AI infrastructure, with some drawing comparisons to other high-flying stocks. Bullish sentiment is fueled by the potential for increased efficiency and reduced energy consumption in AI data centers.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors discuss Shah Capital's push for the company's sale to a larger pharmaceutical entity to unlock shareholder value. The community is debating the potential buyout price, partnership opportunities, and the company's future prospects under new ownership. Some are frustrated with current management, while others remain optimistic about Novavax's fundamentals and technology.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to a planned reverse stock split, which is sparking discussions about potential short squeezes and future price movements. While some traders are optimistic about quick gains, others express concern over the company's history of reverse splits and potential dilution. The community is actively debating the stock's short-term potential versus long-term risks.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp ($LAES) is trending following news of a strategic collaboration with Wecan Group to develop a post-quantum KYC solution, positioning the company as a key player in cybersecurity. The community is buzzing about the potential for a gamma squeeze due to options expiring soon, with some anticipating a significant rise towards double digits. Small cap investors are particularly excited about the upside potential of this stock in the quantum technology and AI revolution.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending due to positive updates on their Alaskan gold and antimony project, including high-grade gold assay results and news of extinguished debt, sparking investor interest. The community is discussing the company's potential to benefit from increased antimony prices and its undervalued status compared to peers. There is also speculation about the company receiving government grants to develop a domestic antimony supply chain.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending as investors discuss the company's acquisition of Astria Therapeutics for $700M, a move aimed at bolstering their HAE portfolio with a late-stage, long-acting plasma kallikrein inhibitor; navenibart. Community chatter revolves around the deal's financial implications, potential dilution, and the strategic shift from in-house development to acquisitions, with some expressing concerns over increased debt and the timeline for potential returns while others are optimistic about the company's strengthened position in the HAE market.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to increasing investor excitement surrounding rare earth mineral stocks and the potential for U.S. government funding to boost domestic supply. Community members are discussing the stock's potential for significant gains amidst rising U.S.-China trade tensions and growing recognition of rare earth elements as vital for national security.

American Resources Corp. engages in the extraction, processing, transportation, and distribution of metallurgical coal to the steel industry. It focuses on the operation of coal mining complexes located primarily within Pike, Knott, and Letcher Counties, Kentucky, and Wyoming County, West Virginia. The company was founded in 2006 and in headquartered in Fishers, IN.

American Resources Corporation - Ordinary Shares - Class A

American Resources Corporation ($AREC) is trending due to ongoing discussions around rare earth elements and critical minerals, particularly following news of a $33M financing deal. The community is debating the implications of potential dilution versus the benefits of increased capital for expansion, especially regarding ReElement Technologies and government interest. Some investors express concerns about past performance and management, while others are optimistic about the company's role in the domestic rare earth supply chain and potential for a ReElement IPO.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics ($CADL) is trending due to positive community sentiment surrounding a recent $130M term loan, viewed as a strategic move to independently advance their lead lung cancer treatment and bypass potential dilution. Investors are actively discussing the implications for future partnerships or a buyout, with many believing the company is positioned for long-term growth and value creation. Community members are also focused on upcoming data releases, particularly related to CAN-3110, and speculating on potential partnership announcements.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community debates its recent price volatility and potential support levels, with some anticipating a drop below $100K while others foresee a sharp reversal and new highs. Discussions also involve the impact of potential trade wars and broader macroeconomic factors on BTC's price action. Some traders point to technical indicators and whale activity as drivers of current market movements.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

The latest trading day saw Cardinal Health (CAH) settling at $154.31, representing a -1.64% change from its previous close.

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Major health care product company files for Chapter 11 bankruptcy

The increased rate of bankruptcy filings by health care providers, organizations, and hospitals over the previous two years has slowed down in 2025 with less than one-third as many petitions filed so...

The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock

Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.

Should You Continue to Hold Bio-Techne Stock in Your Portfolio?

TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.

CAH Expands Distribution Network With Indianapolis Facility

Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts

The latest trading day saw Cardinal Health (CAH) settling at $154.46, representing a -2.52% change from its previous close.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health, Inc.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$152.36
Prev Close	$154.31
Open	$154.34
Dividend Yield	1.21%
50-Day Moving Average	$152.19
Beta	0.34
Avg. Volume	2.26M
PE Ratio	23.96

52-Week High	$168.44
52-Week Low	$106.98
Market Capitalization	$36.85B
EPS (Annual)	$6.45
Price to Book	-13.26
Revenue Per Employee	$3.86M
Enterprise Value/EBITDA	N/A

CAH
Cardinal Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CAH News

CAHCardinal Health, Inc.